Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Eduardo Egea

Omalizumab vs. Placebo in the Management of Chronic Idiopathic Urticaria: A Systematic Review

World Allergy Organization Journal
ImmunologyPulmonaryAllergyRespiratory Medicine
2014English

Análisis Histórico De Las Vasculitis, Su Clasificación Y Propuesta Para Su Entendimiento

Biomedica : revista del Instituto Nacional de Salud
BiochemistryMedicineGeneticsMolecular Biology
1993English

Related publications

Omalizumab in Chronic Urticaria: A Comprehensive Review

Turkderm Deri Hastaliklari ve Frengi Arsivi
DermatologyInfectious Diseases
2018English

Effectiveness of Omalizumab in Adolescent and Adult Patients With Chronic Idiopathic/Spontaneous Urticaria: A Systematic Review of “Real-World” Evidence

Expert Opinion on Biological Therapy
Drug DiscoveryClinical BiochemistryPharmacology
2018English

Re-Evaluation of Need and Tapering of Omalizumab in Chronic Idiopathic Urticaria

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Omalizumab for Chronic Idiopathic Urticaria: Potential to Taper Dose and Frequency?

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Impact of Omalizumab on Patient Reported Outcomes in Chronic Idiopathic Urticaria: Results From XTEND-CIU, a 48-Week, Randomized, Placebo-Controlled Study

Journal of Allergy and Clinical Immunology
AllergyImmunology
2018English

Omalizumab Response in Patients With Chronic Idiopathic Urticaria: Insights From the XTEND-CIU Study

Journal of the American Academy of Dermatology
Dermatology
2018English

Efficacy and Safety of Omalizumab in Patients With Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2015English

Efficacy and Safety of Omalizumab in Patients With Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2015English

Double-Blind Placebo-Controlled Trial of the Effect of Omalizumab on Basophils in Chronic Urticaria Patients

Clinical and Experimental Allergy
AllergyImmunology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy